117 related articles for article (PubMed ID: 9853268)
1. A theoretical four-compartment model to evaluate separate kidney technetium-99m-MAG3 kinetics in humans.
Curti G; DeMartini D; Santaniello B; Taddei G; Fresco GF
Kidney Int; 1998 Dec; 54(6):2029-36. PubMed ID: 9853268
[TBL] [Abstract][Full Text] [Related]
2. Residual kidney function after donor nephrectomy. Assessment by 99mTc-MAG3-clearance.
Hamscho N; Wilhelm A; Döbert N; Menzel C; Gossmann J; Berner U; Zaplatnikov K; Scheuermann EH; Grünwald F
Nuklearmedizin; 2005; 44(5):200-4. PubMed ID: 16395496
[TBL] [Abstract][Full Text] [Related]
3. Effect of arteriovenous difference in measuring renal function by single-injection plasma clearance: role of bolus.
Russell CD; Dubovsky EV
Nucl Med Biol; 1999 Aug; 26(6):699-705. PubMed ID: 10587110
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive measurement of renal function with 99mTc-MAG3 gamma-camera renography based on the one-compartment model.
Oriuchi N; Onishi Y; Kitamura H; Inoue T; Tomaru Y; Higuchi T; Inoue T; Endo K
Clin Nephrol; 1998 Nov; 50(5):289-94. PubMed ID: 9840316
[TBL] [Abstract][Full Text] [Related]
5. [Calculation of renal clearance by dynamic measurement of excreted activity].
Hackstein N; Bauer R
Nuklearmedizin; 1999; 38(2):43-8. PubMed ID: 10100230
[TBL] [Abstract][Full Text] [Related]
6. 99mTc-MAG3: review of pharmacokinetics, clinical application to renal diseases and quantification of renal function.
Itoh K
Ann Nucl Med; 2001 Jun; 15(3):179-90. PubMed ID: 11545186
[TBL] [Abstract][Full Text] [Related]
7. Renal clearance of technetium-99m-MAG3: normal values.
Russell CD; Li Y; Nadiye Kahraman H; Dubovsky EV
J Nucl Med; 1995 Apr; 36(4):706-8. PubMed ID: 7699471
[No Abstract] [Full Text] [Related]
8. Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?
Werner RA; Bluemel C; Lapa C; Muegge DO; Kudlich T; Buck AK; Herrmann K
Nucl Med Commun; 2014 Nov; 35(11):1143-9. PubMed ID: 25171439
[TBL] [Abstract][Full Text] [Related]
9. Deadtime correction in measurement of fractional renal accumulation of 99Tcm-MAG3.
Inoue Y; Ohtake T; Yokoyama I; Yoshikawa K; Ohtomo K
Nucl Med Commun; 1999 Mar; 20(3):267-72. PubMed ID: 10093077
[TBL] [Abstract][Full Text] [Related]
10. Re: Taylor et al.: a 7% decrease in the differential renal uptake of MAG3 implies a loss in renal function (Urology 2010;76:1512-1516).
Zuckier LS
Urology; 2011 Apr; 77(4):1011; author reply 1011-2. PubMed ID: 21477735
[No Abstract] [Full Text] [Related]
11. Tc-99m mercaptoacetyltriglycine clearance: comparison of camera-assisted methods.
Bocher M; Shrem Y; Tappiser A; Klein M; Schechter D; Taylor A; Chisin R
Clin Nucl Med; 2001 Sep; 26(9):745-50. PubMed ID: 11507290
[TBL] [Abstract][Full Text] [Related]
12. [99m-Technetium-mercaptoacetyltriglycine (MAG3) for the demonstration of the kidney changes following extracorporeal shockwave lithotripsy. A prospective study of 117 patients].
Schaub T; Witsch U; el-Damanhoury H; Nägele-Wöhrle B; Hahn K
Rofo; 1992 Oct; 157(4):338-43. PubMed ID: 1391835
[TBL] [Abstract][Full Text] [Related]
13. How gender and age affect iodine-131-OIH and technetium-99m-MAG3 clearance.
Bagni B; Bagni I; Orsolon P; Corazzari T
J Nucl Med Technol; 2000 Sep; 28(3):156-8. PubMed ID: 11001496
[TBL] [Abstract][Full Text] [Related]
14. 99Tcm-N,N-ethylenedicysteine scintigraphy in children with various renal disorders: a comparative study with 99Tcm-MAG3.
Kibar M; Noyan A; Anarat A
Nucl Med Commun; 1997 Jan; 18(1):44-52. PubMed ID: 9061700
[TBL] [Abstract][Full Text] [Related]
15. Multicenter trial validation of a camera-based method to measure Tc-99m mercaptoacetyltriglycine, or Tc-99m MAG3, clearance.
Taylor A; Manatunga A; Morton K; Reese L; Prato FS; Greenberg E; Folks R; Kemp BJ; Jones ME; Corrigan PE; Galt J; Eshima L
Radiology; 1997 Jul; 204(1):47-54. PubMed ID: 9205222
[TBL] [Abstract][Full Text] [Related]
16. Overall accuracy of technetium-99m-MAG3 clearance measurements obtained with a gamma camera heart curve.
Tondeur M; Kinthaert J; Piepsz A; Ham HR
J Nucl Med; 1996 Aug; 37(8):1281-4. PubMed ID: 8708756
[TBL] [Abstract][Full Text] [Related]
17. Can computed tomography volumetry of the renal cortex replace MAG3-scintigraphy in all patients for determining split renal function?
Houbois C; Haneder S; Merkt M; Morelli JN; Schmidt M; Hellmich M; Mueller RU; Wahba R; Maintz D; Puesken M
Eur J Radiol; 2018 Jun; 103():105-111. PubMed ID: 29803374
[TBL] [Abstract][Full Text] [Related]
18. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
Kabasakal L; Turoğlu HT; Onsel C; Ozker K; Uslu I; Atay S; Cansiz T; Sönmezoğlu K; Altiok E; Isitman AT
J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
[TBL] [Abstract][Full Text] [Related]
19. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.
Taylor A; Ziffer JA; Steves A; Eshima D; Delaney VB; Welchel JD
Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734
[TBL] [Abstract][Full Text] [Related]
20. [Quantification of separate renal function using Tc 99m DTPA and Tc 99m DMSA. Correlations between individual isotopic data and creatinine clearance].
Chevet D; Moisan A; Le Pogamp P; Le Cloirec J; Wehbe B; Herry JY
Nephrologie; 1984; 5(1):21-5. PubMed ID: 6328339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
